Legend Biotech Corporation
LEGN
$32.80
-$0.66-1.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 118.15% | -101.46% | 90.86% | 46.66% | -6.58% |
| Total Depreciation and Amortization | 34.57% | 10.40% | 8.03% | 11.07% | 11.45% |
| Total Amortization of Deferred Charges | -54.63% | -37.07% | 212.82% | 7.14% | -46.90% |
| Total Other Non-Cash Items | -164.91% | 5,009.75% | -100.15% | -7,916.85% | 98.40% |
| Change in Net Operating Assets | -682.99% | -579.19% | 142.57% | 433.65% | -119.07% |
| Cash from Operations | 14.18% | -24.61% | 98.31% | 111.15% | -92.28% |
| Capital Expenditure | 45.27% | 61.60% | 43.87% | -46.12% | 33.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -120.75% | 262.57% | -499.10% | -2,025.16% | 1,208.10% |
| Cash from Investing | -121.56% | 257.40% | -471.67% | -2,570.98% | 1,534.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -407.89% | 32.36% | 23.88% | 6.88% | 121.61% |
| Issuance of Common Stock | -2.90% | 101.68% | -99.73% | 329.46% | -0.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -136.00% | 341.73% | -99.88% | 287.16% | 218.14% |
| Foreign Exchange rate Adjustments | -256.46% | 166.84% | -99.62% | 85.43% | 231.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -154.90% | 195.66% | -221.49% | -201.75% | 1,276.85% |